Spine Top Stories Spine BioPharma, Inc. Announces Completion of Enrollment for Phase 3 Clinical Trial of SB-01 to Address Chronic Low Back Pain byJosh SandbergSeptember 24, 2024
Biologics Spine Top Stories Spine BioPharma Announces First Patient Treated in U.S. Phase 3 Clinical Study byChris StewartSeptember 7, 2022
Regulatory Spine Top Stories Spine BioPharma Initiating U.S. Phase 3 Clinical Study byJosh SandbergMay 11, 2022
